RunawayRx
@Runaway_Rx
RunawayRx highlights the impact of rising prescription drug prices on our health care system and encourages a path toward more sustainable, affordable pricing.
New fact sheet! Co-Pay caps might sound like a solution, but they're essentially a blank check for Big Pharma. Let's break it down: - Co-pay caps don't rein in Big Pharma’s pricing power. - Drugmakers can keep raising prices—health plans and patients must cover the difference.…
A recent Reuters analysis found that the median annual list price of new drugs jumped to more than $370,000 in 2024 — up from $300,000 the year before. That’s a 23% increase in just one year. That is not sustainable. 🤔😠 #TheProblemIsThePrice 🔗 Source: Reuters, May 22, 2025…
Mandating GLP-1 coverage without guardrails could send health care spending soaring. Read more in our fact sheet: bit.ly/4iQnPWj
Big Pharma's go-to move? Shifting the blame. ❌ BIG PHARMA’S FALSE CLAIM: Prescription drugs account for a small and stable share of the premium dollar. ✅ THE TRUTH: Prescription drug costs continue to be one of the highest cost drivers of health plan premiums, accounting for…
In the U.S., brand-name weight loss drugs cost FIVE TIMES more than they do in other countries. 💰💰 No, they’re not five times better—just five times more expensive. #BigPharma #TheProblemIsThePrice
#BigPharma calls price negotiation a threat to "innovation” but we call it common sense… Time for #BigPharma to face accountability for their pricing tactics. 💸#TheProblemisthePrice
